Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial

Authors: Nilsson, K., Klevebro, F., Sunde, B., Rouvelas, I., Lindblad, M., Szabo, E., Halldestam, I., Smedh, U., Wallner, B., Johansson, J., Johnsen, G., Aahlin, E.K., Johannessen, H.-O., Alexandersson von Döbeln, G., Hjortland, G.O., Wang, N., Shang, Y., Borg, D., Quaas, A., Bartella, I., Bruns, C., Schröder, W., Nilsson, M.

Source: In Annals of Oncology November 2023 34(11):1015-1024

North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis

Authors: Claassen, Y.H.M., Dikken, J.L., Hartgrink, H.H., de Steur, W.O., Slingerland, M., Verhoeven, R.H.A., van Eycken, E., de Schutter, H., Johansson, J., Rouvelas, I., Johnson, E., Hjortland, G.O., Jensen, L.S., Larsson, H.J., Allum, W.H., Portielje, J.E.A., Bastiaannet, E., van de Velde, C.J.H.

Source: European journal of surgical oncology. 44(12):1982-1989

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100072273367.0x000001&indx=1&recIds=ETOCvdc_100072273367.0x000001

Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas

Authors: Galleberg, R.B., Knigge, U., Tiensuu Janson, E., Vestermark, L.W., Haugvik, S.-P., Ladekarl, M., Langer, S.W., Grønbæk, H., Österlund, P., Hjortland, G.O., Assmus, J., Tang, L., Perren, A., Sorbye, H.

Source: European journal of surgical oncology. 43(9):1682-1689

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100067398570.0x000001&indx=1&recIds=ETOCvdc_100067398570.0x000001

1459P Long-term management and outcomes in gastroesophageal cancer in Norway

Authors: Kolstad, A., Hjortland, G.O., Nilssen, Y., Emanuel, G., Ulvestad, M., Areffard, A., Aahlin, E.

Source: In Annals of Oncology September 2024 35 Supplement 2:S904-S904

1235P Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway

Authors: Helland, A., Hjortland, G.O., Fagereng, L., Bjorge, L., Gilje, B., Cameron, M.G., Donnem, T., Flobak, A., Fluge, S., Nguyen, O.T.D., Mannsåker, B., Stensvold, A., Russnes, H.E.G., Bjørgo, E., Guren, T.K.K., Smeland, S., Tasken, K.

Source: In Annals of Oncology October 2023 34 Supplement 2:S721-S722

International comparison of treatment strategy and survival in metastatic gastric cancer: a survey from the EURECCA Upper GI group

Authors: Claassen, Y., Bastiaannet, E., Hartgrink, H., Dikken, J., De Steur, W., Slingerland, M., Verhoeven, R., Van Eycken, E., De Schutter, H., Lindblad, M., Hedberg, J., Johnson, E., Hjortland, G.O., Jensen, L., Larsson, H., Koessler, T., Chevallay, M., Allum, W., Van de Velde, C.

Source: European journal of surgical oncology. 45(2):e18-e19

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100094530367.0x000001&indx=1&recIds=ETOCvdc_100094530367.0x000001

1108P Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas

Authors: Butt, B.P., Stokmo, H.L., Ladekarl, M., Mitkina Tabaksblat, E., Sorbye, H., Revheim, M.E., Hjortland, G.O.

Source: In Annals of Oncology September 2021 32 Supplement 5:S915-S915

1100MO Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms

Authors: Sorbye, H., Venizelos, A., Elvebakken, H., Perren, A., Lothe, I.M.B., Hjortland, G.O., Sundlov, A., Svensson, J., Garresori, H., Kersten, C., Krogh, M., Detlefsen, S., Knappskog, S.

Source: In Annals of Oncology September 2021 32 Supplement 5:S910-S911

Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines.

Authors: Uzdensky, A.B., Ma, L.-W., Iani, V., Hjortland, G.O., Steen, H.B., Moan, J.

Source: Lasers in Medical Science; Oct2001, Vol. 16 Issue 4, p276-283, 8p

890MO Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients.

Authors: Sorbye, H.¹ (AUTHOR), Knappskog, S.² (AUTHOR), Grob, T.³ (AUTHOR), Venizelos, A.⁴ (AUTHOR), Amstutz, U.⁵ (AUTHOR), Hjortland, G.O.⁶ (AUTHOR), Lothe, I.M.⁷ (AUTHOR), Kersten, C.⁸ (AUTHOR), Hofsli, E.⁹ (AUTHOR), Sundlov, A.¹⁰ (AUTHOR), Elvebakken, H.¹¹ (AUTHOR), Garresori, H.¹² (AUTHOR), Couvelard, A.¹³ (AUTHOR), Svensson, J.¹⁴ (AUTHOR), Perren, A.¹⁵ (AUTHOR)

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS955-S955. 1p.

Subject Terms: *NEUROENDOCRINE tumors, *SOLIDS, *LIQUIDS, *BIOPSY, *MERKEL cell carcinoma